On July 1, 2026, the partial amendment to the Enforcement Rule of South Korea's Consumer Chemical Products and Biocides Safety Control Act (K-BPR) entered into force as Ministry of Climate, Energy and Environment (MCEE) Ordinance No. 48, per the consolidated text on the Korea Law Information Center. The rule revises the procedural machinery, application formats, and risk-assessment steps that biocidal-product and consumer-chemical manufacturers must follow to place goods on the Korean market, aligning the delegated instrument with the parent Act No. 21310 promulgated on December 31, 2025, which took effect the same day.
The amendment matters because the Enforcement Rule (sihaeng gyuchik) is where policy becomes operational: it sets the forms, documentation, validity periods, and step-by-step approval routes that the Act delegates to the MCEE. With both layers now in force, compliance teams handling biocidal active substances, biocidal products, and designated consumer chemical products sold into Korea must update their dossiers and internal workflows to the revised procedures rather than the prior rule text.
What changed in the K-BPR Enforcement Rule on July 1, 2026?
MCEE Ordinance No. 48 is a partial amendment (ilbugaejeong) of the K-BPR Enforcement Rule, the ministerial-level delegated legislation that operationalizes the Consumer Chemical Products and Biocides Safety Control Act. It entered into force on July 1, 2026, the same day the parent Act No. 21310 became effective, closing the gap between the statute and its implementing instrument.
The revised rule restructures the procedures across the Act's core chapters: safety confirmation of designated consumer chemical products (Chapter 2), approval of biocidal active substances and biocidal products (Chapter 3), and the post-market duties of labelling, advertising, quality management, and recall (Chapter 4). It updates the application data requirements, the conditions for substance and product approval, the rules on substance equivalence and product similarity, and the data-protection periods that govern reliance on existing dossiers.
Who must comply, and what products are in scope?
The K-BPR regime, administered by the MCEE with the Ministry of Food and Drug Safety (MFDS) for certain product types, covers biocidal active substances, biocidal products, treated articles, and designated consumer chemical products placed on the Korean market. It was enacted in the wake of the 2011 humidifier-disinfectant disaster and has applied since 2019.
Compliance teams affected by the amendment are those at manufacturers, importers, and Only Representatives who hold or seek biocidal substance or product approvals, who supply designated consumer chemical products subject to safety confirmation, or who place treated articles on the market. Companies that already hold approvals under the prior rule should map their existing dossiers against the revised application-data and equivalence provisions, because the amendment alters the documentation that substantiates an approval and the conditions under which a new applicant can rely on an existing one.
What are the revised approval and risk-assessment procedures?
The amended rule details how the MCEE handles applications for biocidal active-substance approval (Chapter 3, Articles 8 to 19) and biocidal product approval (Articles 19 to 26), including validity periods, change approvals, change notifications, and the recognition of substance equivalence and product similarity that lets later applicants leverage approved reference dossiers. The risk-assessment method for designated consumer chemical products (Chapter 2, Article 4) and the safety-confirmation scheme (Articles 5 to 7) are likewise updated to match the Act's revised scope.
Post-market obligations under Chapter 4 are restated through the amended rule: limits on labelling and advertising, the duty to report newly identified hazards, the quality-management obligation, and the conditions for recall orders and administrative surcharges. The rule also fixes the relief scheme for harm caused by biocidal products (Chapter 5-2), setting the grant categories, investigation and appraisal procedure, and the contribution mechanism that funds the scheme.
| Instrument | Layer | Status |
|---|---|---|
| Act No. 21310 (K-BPR parent Act) | Statute, National Assembly | Promulgated December 31, 2025; in force July 1, 2026 |
| MCEE Ordinance No. 48 (Enforcement Rule) | Ministerial delegated legislation | In force July 1, 2026 |
| Biocidal substance and product approval | Administrative, MCEE | Revised application data and procedures |
| Consumer chemical product safety confirmation | Administrative, MCEE and MFDS | Revised risk-assessment method |
What should compliance teams do now?
Because both the Act and the amended Enforcement Rule are already in force, the window for preparation has closed and the operative question is conformity. Teams should, first, retrieve the consolidated text from the Korea Law Information Center and confirm whether their product categories fall under the revised safety-confirmation or approval routes. Second, audit existing approvals and dossiers against the amended application-data requirements, paying attention to validity periods, change-notification triggers, and the data-protection windows that govern reliance on reference dossiers. Third, update internal labelling, advertising-review, quality-management, and recall procedures to the restated Chapter 4 duties, and brief the regulatory and product-safety functions on the revised biocidal-product relief scheme.
Continuous, per-jurisdiction monitoring of the kind Obsidian provides surfaces an Enforcement Rule amendment the moment the MCEE publishes it, so the gap between a parent Act and its implementing rule never catches a compliance programme unprepared.
Follow this topic in real time with a free monitoring job
Next steps: confirm applicability against the consolidated rule text, map your dossiers to the revised procedures, and brief the teams that hold Korean biocidal or consumer-chemical approvals before the next audit cycle.
